Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03008876 · ClinicalTrials.gov registry record · NA
IV Acetaminophen and Patent Ductus Arteriosus
A NA study, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03008876 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 10 participants.
The verdict
NCT03008876, a NA study, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to evaluate the efficacy of IV acetaminophen versus IV ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm infants.
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03008876
The ClinicalTrials.gov registry entry for NCT03008876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT03008876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03008876 about?
NCT03008876 is a clinical study titled "IV Acetaminophen and Patent Ductus Arteriosus". This is a randomized controlled trial to evaluate the efficacy of IV acetaminophen versus IV ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm infants.
What is the current status of trial NCT03008876?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-01-01. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03008876?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT03008876?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.